These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 6684466

  • 1. High-resolution autoradiography in mouse brain 24 h after radiolabelled CDP-choline administration.
    Romero A, Serratosa J, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1056-8. PubMed ID: 6684466
    [Abstract] [Full Text] [Related]

  • 2. High-resolution autoradiography in mouse brain and cerebellum 10 days after radiolabelled CDP-choline administration.
    Romero A, Serratosa J, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1058-60. PubMed ID: 6684467
    [Abstract] [Full Text] [Related]

  • 3. Low-resolution autoradiography in rat brain after administering labelled CDP-choline.
    Romero A, Serratosa J, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1054-6. PubMed ID: 6684465
    [Abstract] [Full Text] [Related]

  • 4. Cerebral subcellular distribution of CDP-choline and/or its metabolites after oral administration of methyl-14C CDP-choline.
    Aguilar J, Giménez R, Bachs O, Enrich C, Agut J.
    Arzneimittelforschung; 1983; 33(7A):1051-3. PubMed ID: 6225438
    [Abstract] [Full Text] [Related]

  • 5. Radioactivity incorporation into different cerebral phospholipids after oral administration of 14C methyl CDP-choline.
    Agut J, Font E, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1048-50. PubMed ID: 6684464
    [Abstract] [Full Text] [Related]

  • 6. Bioavailability of methyl-14C CDP-choline by oral route.
    Agut J, Font E, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983; 33(7A):1045-7. PubMed ID: 6684463
    [Abstract] [Full Text] [Related]

  • 7. Studies on the intrathecal pharmacotherapy. Part I: CDP-choline.
    Ogashiwa M, Takeuchi K, Hara M, Tanaka Y, Okada J.
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):327-35. PubMed ID: 1242132
    [Abstract] [Full Text] [Related]

  • 8. Dissimilar effects in acute toxicity studies of CDP-choline and choline.
    Agut J, Font E, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Oct; 33(7A):1016-8. PubMed ID: 6684453
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of 14C CDP-choline.
    Dinsdale JR, Griffiths GK, Rowlands C, Castelló J, Ortiz JA, Maddock J, Aylward M.
    Arzneimittelforschung; 1983 Oct; 33(7A):1066-70. PubMed ID: 6412727
    [Abstract] [Full Text] [Related]

  • 10. CDP-choline: acute toxicity study.
    Grau T, Romero A, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Oct; 33(7A):1033-4. PubMed ID: 6684459
    [Abstract] [Full Text] [Related]

  • 11. The effect of cytidine-diphosphate choline (CDP-choline) on brain lipid changes during aging.
    De Medio GE, Trovarelli G, Piccinin GL, Porcellati G.
    J Neurosci Res; 1984 Oct; 11(1):49-58. PubMed ID: 6708133
    [Abstract] [Full Text] [Related]

  • 12. Study on the protection of CDP-choline against nicotine intoxication.
    Grau T, Romero A, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Oct; 33(7A):1025-6. PubMed ID: 6684456
    [Abstract] [Full Text] [Related]

  • 13. Cytidine diphosphate choline (citicoline, Somazina).
    Arzneimittelforschung; 1983 Oct; 33(7A):1011-80. PubMed ID: 6684451
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacological study of oral CDP-choline. Interaction with oxotremorine on the parasympathetic system.
    Tornos ME, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Oct; 33(7A):1026-9. PubMed ID: 6684457
    [Abstract] [Full Text] [Related]

  • 15. Study of the effects of oral administration of CDP-choline on EEG changes and lethality induced by epidural compression in the anaesthetised cat.
    Algate DR, Beard DJ, Sacristán A, Ortiz JA, Davies JE.
    Arzneimittelforschung; 1983 Oct; 33(7A):1013-6. PubMed ID: 6684452
    [Abstract] [Full Text] [Related]

  • 16. Involvement of CDP-choline in phospholipid metabolism of brain tissue in vitro.
    Arienti G, Corazzi L, Mastrofini P, Montanini I, Tirillini B, Porcellati G.
    Ital J Biochem; 1979 Oct; 28(1):39-45. PubMed ID: 553079
    [Abstract] [Full Text] [Related]

  • 17. Effect of oral CDP-choline on experimental withdrawal syndrome.
    Tornos ME, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Oct; 33(7A):1018-21. PubMed ID: 6684454
    [Abstract] [Full Text] [Related]

  • 18. Study of subacute toxicity of CDP-choline after 30 days of oral administration to rats.
    Romero A, Grau T, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Oct; 33(7A):1035-8. PubMed ID: 6684460
    [Abstract] [Full Text] [Related]

  • 19. CDP-choline: 6-month study on toxicity in dogs.
    Romero A, Grau T, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Oct; 33(7A):1038-42. PubMed ID: 6684461
    [Abstract] [Full Text] [Related]

  • 20. Effect of oral CDP-choline on acrylamide-induced lesion.
    Agut J, Font E, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1983 Oct; 33(7A):1029-33. PubMed ID: 6684458
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.